Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias

Adenosine has been shown to affect both sinus node automaticity and atrioventricular (AV) nodal conduction. The effects of increasing doses of intravenous adenosine were assessed in 46 patients with supraventricular tachyarrhythmias. Adenosine reliably terminated episodes of supraventricular tachycardia in all 16 patients with AV reciprocating tachycardia, in 13 of 13 patients with AV nodal reentrant tachycardia and in 1 of 2 patients with junctional tachycardia with long RP intervals. Adenosine produced transient high grade AV block without any effect on atrial activity in six patients with intraatrial reentrant tachycardia, four patients with atrial flutter, three patients with atrial fibrillation and in single patients with either sinus node reentry or an automatic atrial tachycardia. The dose of adenosine required to terminate episodes of supraventricular tachycardia was variable (range 2 to 23 mg). Side effects were minor and of short duration. These results demonstrate that adenosine is useful for the acute therapy of supraventricular tachycardia whenever reentry through the AV node is involved. When arrhythmia termination is not affected, atrial activity may be more readily analyzed during adenosine-induced transient AV block.

This article has been cited by other articles:

				H. L. Collins and S. E. DiCarlo Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1020 - H1026. [Abstract] [Full Text] [PDF]

				J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF]

				E. N. Prystowsky, I. Niazi, A. B. Curtis, D. J. Wilber, T. Bahnson, K. Ellenbogen, A. Dhala, D. M. Bloomfield, M. Gold, A. Kadish, et al. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510),a novel A1-adenosine receptor agonist J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1098 - 1102. [Abstract] [Full Text] [PDF]

				L. Wu, L. Belardinelli, J. A. Zablocki, V. Palle, and J. C. Shryock A partial agonist of the A1-adenosine receptor selectively slows AV conduction in guinea pig hearts Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H334 - H343. [Abstract] [Full Text] [PDF]

				F L. Pasini, P. Capecchi, and T Di Perri Adenosine and chronic ischemia of the lower limbs Vascular Medicine, November 1, 2000; 5(4): 243 - 250. [Abstract] [PDF]

				J C Hancox, K C R Patel, and J V Jones Antiarrhythmics---from cell to clinic: past, present, and future Heart, July 1, 2000; 84(1): 14 - 24. [Full Text] [PDF]

				K. A. Glatter, J. Cheng, P. Dorostkar, G. Modin, S. Talwar, M. Al-Nimri, R. J. Lee, L. A. Saxon, M. D. Lesh, and M. M. Scheinman Electrophysiologic Effects of Adenosine in Patients With Supraventricular Tachycardia Circulation, March 2, 1999; 99(8): 1034 - 1040. [Abstract] [Full Text] [PDF]

				J V De Giovanni, R A Edgar, and A Cranston Adenosine induced transient cardiac standstill in catheter interventional procedures for congenital heart disease Heart, October 1, 1998; 80(4): 330 - 333. [Abstract] [Full Text]

				E Jaeggi, J C Fouron, A Fournier, N van Doesburg, S P Drblik, and F Proulx Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia Heart, June 1, 1998; 79(6): 582 - 587. [Abstract] [Full Text]

				K. Kwong, J.-L. Hong, R. F. Morton, and L.-Y. Lee Role of pulmonary C fibers in adenosine-induced respiratory inhibition in anesthetized rats J Appl Physiol, February 1, 1998; 84(2): 417 - 424. [Abstract] [Full Text] [PDF]

				M. P. S. Randhawa Jr., R. D. Lasley, and R. M. Mentzer Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 63 - 74. [Abstract] [Full Text]

				J. B. Conti, L. Belardinelli, D. B. Utterback, and A. B. Curtis Endogenous Adenosine Is an Antiarrhythmic Agent Circulation, March 15, 1995; 91(6): 1761 - 1767. [Abstract] [Full Text]

				L. I. Ganz and P. L. Friedman Supraventricular Tachycardia N. Engl. J. Med., January 19, 1995; 332(3): 162 - 173. [Full Text] [PDF]

				S. J. Getschman, A. M. Dietrich, W. H. Franklin, and H. D. Allen Intraosseous Adenosine: As Effective as Peripheral or Central Venous Administration? Arch Pediatr Adolesc Med, June 1, 1994; 148(6): 616 - 619. [Abstract] [PDF]

				M. A. Brodsky, B. J. Allen, J. A. Grimes, and C. Gold Enhanced Atrioventricular Conduction during Atrial Flutter after Intravenous Adenosine N. Engl. J. Med., January 27, 1994; 330(4): 288 - 289. [Full Text]

				E. S. W. Ben-Sorek and J. Wiesel Ventricular Fibrillation Following Adenosine Administration: A Case Report Arch Intern Med, December 13, 1993; 153(23): 2701 - 2702. [Abstract] [PDF]

				Adult Advanced Cardiac Life Support JAMA, October 28, 1992; 268(16): 2199 - 2241. [Abstract] [PDF]

				J. Vatz, S. C. Hammill, and D. Cooke Radiofrequency Catheter Ablation of Aberrant Conducting Pathways of the Heart JAMA, October 21, 1992; 268(15): 2091 - 2098. [PDF]

				A. C. Rankin and B. A. McGovern Adenosine or Verapamil for the Acute Treatment of Supraventricular Tachycardia? Ann Intern Med, March 15, 1991; 114(6): 513 - 515. [Abstract] [PDF]

				J. P. DiMarco, W. Miles, M. Akhtar, S. Milstein, A. D. Sharma, E. Platia, B. McGovern, M. M. Scheinman, and W. C. Govier Adenosine for Paroxysmal Supraventricular Tachycardia: Dose Ranging and Comparison with Verapamil: Assessment in Placebo-Controlled, Multicenter Trials Ann Intern Med, July 15, 1990; 113(2): 104 - 110. [Abstract] [PDF]